vs

Side-by-side financial comparison of IMPINJ INC (PI) and Beauty Health Co (SKIN). Click either name above to swap in a different company.

Beauty Health Co is the larger business by last-quarter revenue ($82.4M vs $74.3M, roughly 1.1× IMPINJ INC). IMPINJ INC runs the higher net margin — 11.2% vs -9.8%, a 21.0% gap on every dollar of revenue. On growth, IMPINJ INC posted the faster year-over-year revenue change (-0.0% vs -1.3%). Beauty Health Co produced more free cash flow last quarter ($15.1M vs $2.2M). Over the past eight quarters, Beauty Health Co's revenue compounded faster (0.6% CAGR vs -14.9%).

Impinj, Inc. is an American manufacturer of radio-frequency identification (RFID) devices and software. The company was founded in 2000 and is headquartered in Seattle, Washington. The company was started based on the research done at the California Institute of Technology by Carver Mead and Chris Diorio. Impinj currently produces EPC Class 1, Gen 2 passive UHF RFID chips, RFID readers, RFID reader chips, and RFID antennas, and software applications for encoding chips, and gathering business ...

Rare Beauty is an American cosmetics company founded by singer and actress Selena Gomez. Launched on September 3, 2020, the brand takes its name from Gomez’s third studio album, Rare (2020). Rare Beauty is sold through its official website, Sephora And Ulta beauty stores in multiple regions, including North America, Europe, Asia, and the Middle East.

PI vs SKIN — Head-to-Head

Bigger by revenue
SKIN
SKIN
1.1× larger
SKIN
$82.4M
$74.3M
PI
Growing faster (revenue YoY)
PI
PI
+1.3% gap
PI
-0.0%
-1.3%
SKIN
Higher net margin
PI
PI
21.0% more per $
PI
11.2%
-9.8%
SKIN
More free cash flow
SKIN
SKIN
$12.8M more FCF
SKIN
$15.1M
$2.2M
PI
Faster 2-yr revenue CAGR
SKIN
SKIN
Annualised
SKIN
0.6%
-14.9%
PI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PI
PI
SKIN
SKIN
Revenue
$74.3M
$82.4M
Net Profit
$8.3M
$-8.1M
Gross Margin
49.1%
64.4%
Operating Margin
30.5%
0.2%
Net Margin
11.2%
-9.8%
Revenue YoY
-0.0%
-1.3%
Net Profit YoY
21.5%
EPS (diluted)
$0.14
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PI
PI
SKIN
SKIN
Q1 26
$74.3M
Q4 25
$92.8M
$82.4M
Q3 25
$96.1M
$70.7M
Q2 25
$97.9M
$78.2M
Q1 25
$74.3M
$69.6M
Q4 24
$91.6M
$83.5M
Q3 24
$95.2M
$78.8M
Q2 24
$102.5M
$90.6M
Net Profit
PI
PI
SKIN
SKIN
Q1 26
$8.3M
Q4 25
$-1.1M
$-8.1M
Q3 25
$-12.8M
$-11.0M
Q2 25
$11.6M
$19.7M
Q1 25
$-8.5M
$-10.1M
Q4 24
$-2.7M
$-10.3M
Q3 24
$221.0K
$-18.3M
Q2 24
$10.0M
$202.0K
Gross Margin
PI
PI
SKIN
SKIN
Q1 26
49.1%
Q4 25
51.8%
64.4%
Q3 25
50.3%
64.6%
Q2 25
57.8%
62.8%
Q1 25
49.4%
69.8%
Q4 24
50.5%
62.7%
Q3 24
50.0%
51.6%
Q2 24
56.1%
45.2%
Operating Margin
PI
PI
SKIN
SKIN
Q1 26
30.5%
Q4 25
-2.9%
0.2%
Q3 25
0.7%
-8.8%
Q2 25
11.1%
-3.5%
Q1 25
-12.9%
-17.3%
Q4 24
-3.9%
-8.6%
Q3 24
-0.8%
-27.3%
Q2 24
8.8%
-24.4%
Net Margin
PI
PI
SKIN
SKIN
Q1 26
11.2%
Q4 25
-1.2%
-9.8%
Q3 25
-13.3%
-15.6%
Q2 25
11.8%
25.2%
Q1 25
-11.4%
-14.5%
Q4 24
-2.9%
-12.4%
Q3 24
0.2%
-23.2%
Q2 24
9.7%
0.2%
EPS (diluted)
PI
PI
SKIN
SKIN
Q1 26
$0.14
Q4 25
$-0.02
$-0.02
Q3 25
$-0.44
$-0.09
Q2 25
$0.39
$0.03
Q1 25
$-0.30
$-0.08
Q4 24
$-0.06
$-0.01
Q3 24
$0.01
$-0.15
Q2 24
$0.34
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PI
PI
SKIN
SKIN
Cash + ST InvestmentsLiquidity on hand
$131.8M
Total DebtLower is stronger
$241.5M
Stockholders' EquityBook value
$61.1M
Total Assets
$502.5M
$499.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PI
PI
SKIN
SKIN
Q1 26
$131.8M
Q4 25
$175.3M
Q3 25
$190.1M
Q2 25
$193.2M
Q1 25
$147.9M
Q4 24
$164.7M
Q3 24
$170.3M
Q2 24
$220.2M
Total Debt
PI
PI
SKIN
SKIN
Q1 26
$241.5M
Q4 25
$280.9M
Q3 25
$280.4M
$363.4M
Q2 25
$363.1M
Q1 25
Q4 24
$283.5M
$552.2M
Q3 24
Q2 24
Stockholders' Equity
PI
PI
SKIN
SKIN
Q1 26
Q4 25
$209.2M
$61.1M
Q3 25
$195.0M
$65.7M
Q2 25
$187.7M
$74.0M
Q1 25
$160.6M
$46.1M
Q4 24
$149.9M
$51.8M
Q3 24
$136.1M
$59.7M
Q2 24
$117.0M
$69.2M
Total Assets
PI
PI
SKIN
SKIN
Q1 26
$502.5M
Q4 25
$545.2M
$499.8M
Q3 25
$516.5M
$503.6M
Q2 25
$508.8M
$507.6M
Q1 25
$479.8M
$673.8M
Q4 24
$489.1M
$685.7M
Q3 24
$476.4M
$699.5M
Q2 24
$446.1M
$711.8M
Debt / Equity
PI
PI
SKIN
SKIN
Q1 26
Q4 25
1.34×
Q3 25
1.44×
5.53×
Q2 25
4.91×
Q1 25
Q4 24
1.89×
10.66×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PI
PI
SKIN
SKIN
Operating Cash FlowLast quarter
$15.2M
Free Cash FlowOCF − Capex
$2.2M
$15.1M
FCF MarginFCF / Revenue
3.0%
18.3%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$61.1M
$37.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PI
PI
SKIN
SKIN
Q1 26
Q4 25
$15.1M
$15.2M
Q3 25
$20.9M
$9.6M
Q2 25
$33.9M
$9.6M
Q1 25
$-11.1M
$3.0M
Q4 24
$12.6M
$16.5M
Q3 24
$10.1M
$10.3M
Q2 24
$45.5M
$6.2M
Free Cash Flow
PI
PI
SKIN
SKIN
Q1 26
$2.2M
Q4 25
$13.6M
$15.1M
Q3 25
$18.0M
$9.6M
Q2 25
$27.3M
$9.6M
Q1 25
$-13.0M
$3.0M
Q4 24
$8.5M
$16.4M
Q3 24
$4.7M
$10.3M
Q2 24
$44.1M
$5.9M
FCF Margin
PI
PI
SKIN
SKIN
Q1 26
3.0%
Q4 25
14.7%
18.3%
Q3 25
18.7%
13.6%
Q2 25
27.9%
12.2%
Q1 25
-17.5%
4.2%
Q4 24
9.3%
19.6%
Q3 24
4.9%
13.1%
Q2 24
43.0%
6.5%
Capex Intensity
PI
PI
SKIN
SKIN
Q1 26
Q4 25
1.6%
0.2%
Q3 25
3.1%
0.0%
Q2 25
6.7%
0.1%
Q1 25
2.5%
0.1%
Q4 24
4.5%
0.1%
Q3 24
5.7%
0.0%
Q2 24
1.3%
0.4%
Cash Conversion
PI
PI
SKIN
SKIN
Q1 26
Q4 25
Q3 25
Q2 25
2.93×
0.49×
Q1 25
Q4 24
Q3 24
45.56×
Q2 24
4.56×
30.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PI
PI

Segment breakdown not available.

SKIN
SKIN

Consumables$57.7M70%
Delivery Systems$24.7M30%

Related Comparisons